Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CHATTEM CONSUMER PRODUCTS DRIVE FIRST QUARTER CORPORATE SALES TO 8% GAIN

This article was originally published in The Tan Sheet

Executive Summary

CHATTEM CONSUMER PRODUCTS DRIVE FIRST QUARTER CORPORATE SALES TO 8% GAIN to $ 21.2 mil., the Chattanooga, Tenn.-based OTC/H&BA company reported. For the three month period ended Feb. 28, Chattem's earnings before an extraordinary charge increased 245% to $ 1.41 mil., up from $ 408,000 in the first quarter of 1992. Net income after the extraordinary charge, which was taken to account for the retirement of debt, grew 127% to $ 927,000, the company said. "From a divisional perspective, Chattem Consumer Products experienced a significant increase in sales and operating income, led by solid performances by [pain relieving gel] Flex-all 454, [the water-durable sunblock] Bullfrog, and [oil absorbing cosmetic line] Corn Silk," Chattem stated. The company cited "a shift in product mix, improved gross margins, cost controls and operating leverage" to explain why the company's earnings are rising faster than sales. Chattem plans to begin running print ads for its Bullfrog Sport Lotion SPF 18 in speciality magazines in May. "Sweatproof" and "non-greasy," the sport lotion provides "all day waterproof protection with one application" and screens both UVA and UVB rays, according to the company. An umbrella print and billboard ad campaign for the Bullfrog brand, which also features a PABA-free SPF 18 Extra Moisturizing Gel, will also begin in May. Chattem expects to further support the line with product sampling. Chattem said that its cash and investments exceeded debt by nearly $ 8 mil. at the end of the quarter. The company reported that it plans to retire its $ 25 mil. in currently outstanding debt "utilizing cash and investments." Anticipating the payment, the extraordinary non-cash charge was estimated at $ 480,000, or $ .09 per share. Included in first quarter results, Chattem noted, is a gain of approximately $ .10 a share, or about $ 550,000, from the company's sale of "two minor consumer products" -- Black Draught laxative and Nullo internal deodorant tablet. The company's chemicals subsidiary showed "essentially flat" sales compared with "a very strong first quarter of 1992," Chattem reported. In addition, the company said its international consumer product operations "remained soft, reflecting the weak economies in the key markets served by the division." Chart omitted.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS081286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel